Neogen Corp (NEOG)
12.35
+0.10
(+0.82%)
USD |
NASDAQ |
May 02, 13:25
Neogen Enterprise Value: 3.373B for May 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 01, 2024 | 3.373B |
| April 30, 2024 | 3.390B |
| April 29, 2024 | 3.409B |
| April 26, 2024 | 3.349B |
| April 25, 2024 | 3.310B |
| April 24, 2024 | 3.399B |
| April 23, 2024 | 3.386B |
| April 22, 2024 | 3.271B |
| April 19, 2024 | 3.234B |
| April 18, 2024 | 3.303B |
| April 17, 2024 | 3.349B |
| April 16, 2024 | 3.353B |
| April 15, 2024 | 3.321B |
| April 12, 2024 | 3.401B |
| April 11, 2024 | 3.535B |
| April 10, 2024 | 3.427B |
| April 09, 2024 | 3.544B |
| April 08, 2024 | 3.834B |
| April 05, 2024 | 3.828B |
| April 04, 2024 | 3.769B |
| April 03, 2024 | 3.808B |
| April 02, 2024 | 3.858B |
| April 01, 2024 | 3.986B |
| March 28, 2024 | 4.137B |
| March 27, 2024 | 4.068B |
| Date | Value |
|---|---|
| March 26, 2024 | 3.968B |
| March 25, 2024 | 4.009B |
| March 22, 2024 | 4.014B |
| March 21, 2024 | 4.066B |
| March 20, 2024 | 4.098B |
| March 19, 2024 | 3.992B |
| March 18, 2024 | 3.983B |
| March 15, 2024 | 4.007B |
| March 14, 2024 | 4.022B |
| March 13, 2024 | 4.100B |
| March 12, 2024 | 4.168B |
| March 11, 2024 | 4.226B |
| March 08, 2024 | 4.265B |
| March 07, 2024 | 4.350B |
| March 06, 2024 | 4.343B |
| March 05, 2024 | 4.350B |
| March 04, 2024 | 4.454B |
| March 01, 2024 | 4.443B |
| February 29, 2024 | 4.443B |
| February 28, 2024 | 4.363B |
| February 27, 2024 | 4.396B |
| February 26, 2024 | 4.307B |
| February 23, 2024 | 4.329B |
| February 22, 2024 | 4.383B |
| February 21, 2024 | 4.372B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.826B
Minimum
Aug 24 2022
5.797B
Maximum
Aug 15 2023
3.755B
Average
3.792B
Median
Dec 08 2020
Enterprise Value Benchmarks
| Moderna Inc | 34.07B |
| SIGA Technologies Inc | 512.43M |
| Syros Pharmaceuticals Inc | 45.61M |
| Disc Medicine Inc | 343.03M |
| Amylyx Pharmaceuticals Inc | -240.54M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.022M |
| Revenue (Quarterly) | 228.81M |
| Total Expenses (Quarterly) | 216.79M |
| EPS Diluted (Quarterly) | -0.01 |
| Gross Profit Margin (Quarterly) | 51.08% |
| Profit Margin (Quarterly) | -0.88% |
| Earnings Yield | 0.05% |
| Operating Earnings Yield | 2.58% |
| Normalized Earnings Yield | 0.1702 |